Filing Flows › Neuraxis (NRXS) › Q1 2025
Neuraxis (NRXS) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 12, 2025
Neuraxis (NRXS) reported revenue of $896K for the first quarter 2025 (Q1 2025), +39% from a year earlier and +18% from the quarter before. Operating margin was -256.2%, net loss $2.3M (254.4% of revenue).
Neuraxis, Q1 2025: revenue $896K (+38% year over year), operating margin -256.2%, net loss $2.3M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $896K | +18% | +39% |
| Operating profit | −$2.3M | — | — |
| Net earnings | −$2.3M | — | — |
| Operating cash flow | −$1.6M | — | — |
What changed
Revenue was $896K in Q1 2025, up 39% year over year and up 18% from the previous quarter.
Gross margin was 84.4%, down 4.0 points from a year earlier. Operating costs exceeded revenue by $2.3M, an operating margin of -256.2%. Operating expenses grew 27% against revenue growth of 39%. The fastest-growing cost line was Research & development (+987%). The quarter ended with a net loss of $2.3M, wider than the previous quarter's $1.4M loss.
Operating cash flow was −$1.6M. Non-cash charges added back $6K of depreciation and amortization and $106K of share-based compensation. Working capital and other items added $563K. Capital expenditures of $18K exceeded it, leaving free cash flow of −$1.6M.
Questions
What was Neuraxis' revenue in the first quarter 2025?
Neuraxis (NRXS) reported revenue of $896K for the first quarter 2025 (Q1 2025), +39% from a year earlier and +18% from the quarter before.
Was Neuraxis profitable in the first quarter 2025?
Operating loss was $2.3M (-256.2% of revenue) and net loss $2.3M.
Source: Neuraxis 10-Q on SEC EDGAR.